57 results on '"Bruner-Tran KL"'
Search Results
2. A Paternal Fish Oil Diet Preconception Reduces Lung Inflammation in a Toxicant-Driven Murine Model of New Bronchopulmonary Dysplasia.
- Author
-
Rumph JT, Stephens VR, Ameli S, Brown LK, Rayford KJ, Nde PN, Osteen KG, and Bruner-Tran KL
- Subjects
- Humans, Infant, Newborn, Male, Infant, Pregnancy, Animals, Female, Child, Mice, Disease Models, Animal, Lung pathology, Fish Oils pharmacology, Fathers, Diet, Bronchopulmonary Dysplasia prevention & control, Bronchopulmonary Dysplasia pathology, Pneumonia, Premature Birth, Polychlorinated Dibenzodioxins, Dietary Fats, Unsaturated
- Abstract
New bronchopulmonary dysplasia (BPD) is a neonatal disease that is theorized to begin in utero and manifests as reduced alveolarization due to inflammation of the lung. Risk factors for new BPD in human infants include intrauterine growth restriction (IUGR), premature birth (PTB) and formula feeding. Using a mouse model, our group recently reported that a paternal history of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure increased his offspring's risk of IUGR, PTB, and new BPD. Additionally, formula supplementation of these neonates worsened the severity of pulmonary disease. In a separate study, we reported that a paternal preconception fish oil diet prevented TCDD-driven IUGR and PTB. Not surprisingly, eliminating these two major risk factors for new BPD also significantly reduced development of neonatal lung disease. However, this prior study did not examine the potential mechanism for fish oil's protective effect. Herein, we sought to determine whether a paternal preconception fish oil diet attenuated toxicant-associated lung inflammation, which is an important contributor to the pathogenesis of new BPD. Compared to offspring of standard diet TCDD-exposed males, offspring of TCDD-exposed males provided a fish oil diet prior to conception exhibited a significant reduction in pulmonary expression of multiple pro-inflammatory mediators ( Tlr4 , Cxcr2 , Il-1 alpha ). Additionally, neonatal lungs of pups born to fish oil treated fathers exhibited minimal hemorrhaging or edema. Currently, prevention of BPD is largely focused on maternal strategies to improve health (e.g., smoking cessation) or reduce risk of PTB (e.g., progesterone supplementation). Our studies in mice support a role for also targeting paternal factors to improve pregnancy outcomes and child health.
- Published
- 2023
- Full Text
- View/download PDF
3. A Paternal Fish Oil Diet Preconception Modulates the Gut Microbiome and Attenuates Necrotizing Enterocolitis in Neonatal Mice.
- Author
-
Rumph JT, Stephens VR, Ameli S, Gaines PN, Osteen KG, Bruner-Tran KL, and Nde PN
- Subjects
- Animals, Animals, Newborn, Diet, Female, Fish Oils pharmacology, Humans, Male, Mice, Dietary Fats, Unsaturated, Enterocolitis, Necrotizing etiology, Enterocolitis, Necrotizing prevention & control, Gastrointestinal Microbiome, Polychlorinated Dibenzodioxins, Premature Birth
- Abstract
Epidemiology and animal studies suggest that a paternal history of toxicant exposure contributes to the developmental origins of health and disease. Using a mouse model, our laboratory previously reported that a paternal history of in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increased his offspring's risk of developing necrotizing enterocolitis (NEC). Additionally, our group and others have found that formula supplementation also increases the risk of NEC in both humans and mice. Our murine studies revealed that intervening with a paternal fish oil diet preconception eliminated the TCDD-associated outcomes that are risk factors for NEC (e.g., intrauterine growth restriction, delayed postnatal growth, and preterm birth). However, the efficacy of a paternal fish oil diet in eliminating the risk of disease development in his offspring was not investigated. Herein, reproductive-age male mice exposed to TCDD in utero were weaned to a standard or fish oil diet for one full cycle of spermatogenesis, then mated to age-matched unexposed females. Their offspring were randomized to a strict maternal milk diet or a supplemental formula diet from postnatal days 7-10. Offspring colon contents and intestines were collected to determine the onset of gut dysbiosis and NEC. We found that a paternal fish oil diet preconception reduced his offspring's risk of toxicant-driven NEC, which was associated with a decrease in the relative abundance of the Firmicutes phylum, but an increase in the relative abundance of the Negativicutes class.
- Published
- 2022
- Full Text
- View/download PDF
4. The Potential Relationship Between Environmental Endocrine Disruptor Exposure and the Development of Endometriosis and Adenomyosis.
- Author
-
Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL, and Osteen KG
- Abstract
Women with endometriosis, the growth of endometrial glands and stroma outside the uterus, commonly also exhibit adenomyosis, the growth of endometrial tissues within the uterine muscle. Each disease is associated with functional alterations in the eutopic endometrium frequently leading to pain, reduced fertility, and an increased risk of adverse pregnancy outcomes. Although the precise etiology of either disease is poorly understood, evidence suggests that the presence of endometriosis may be a contributing factor to the subsequent development of adenomyosis as a consequence of an altered, systemic inflammatory response. Herein, we will discuss the potential role of exposure to environmental toxicants with endocrine disrupting capabilities in the pathogenesis of both endometriosis and adenomyosis. Numerous epidemiology and experimental studies support a role for environmental endocrine disrupting chemicals (EDCs) in the development of endometriosis; however, only a few studies have examined the potential relationship between toxicant exposures and the risk of adenomyosis. Nevertheless, since women with endometriosis are also frequently found to have adenomyosis, discussion of EDC exposure and development of each of these diseases is relevant. We will discuss the potential mechanisms by which EDCs may act to promote the co-development of endometriosis and adenomyosis. Understanding the disease-promoting mechanisms of environmental toxicants related to endometriosis and adenomyosis is paramount to designing more effective treatment(s) and preventative strategies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Stephens, Rumph, Ameli, Bruner-Tran and Osteen.)
- Published
- 2022
- Full Text
- View/download PDF
5. Uncovering Evidence: Associations between Environmental Contaminants and Disparities in Women's Health.
- Author
-
Rumph JT, Stephens VR, Martin JL, Brown LK, Thomas PL, Cooley A, Osteen KG, and Bruner-Tran KL
- Subjects
- Environmental Exposure adverse effects, Female, Hazardous Substances, Humans, Pregnancy, Women's Health, Dioxins toxicity, Endocrine Disruptors toxicity, Environmental Pollutants, Polychlorinated Biphenyls toxicity
- Abstract
Over the years, industrial accidents and military actions have led to unintentional, large-scale, high-dose human exposure to environmental contaminants with endocrine-disrupting action. These historical events, in addition to laboratory studies, suggest that exposure to toxicants such as dioxins and polychlorinated biphenyls negatively impact the reproductive system and likely influence the development of gynecologic diseases. Although high-level exposure to a single toxicant is rare, humans living in industrialized countries are continuously exposed to a complex mixture of manmade and naturally produced endocrine disruptors, including persistent organic pollutants and heavy metals. Since minorities are more likely to live in areas with known environmental contamination; herein, we conducted a literature review to identify potential associations between toxicant exposure and racial disparities in women's health. Evidence within the literature suggests that the body burden of environmental contaminants, especially in combination with inherent genetic variations, likely contributes to previously observed racial disparities in women's health conditions such as breast cancer, endometriosis, polycystic ovarian syndrome, uterine fibroids, and premature birth.
- Published
- 2022
- Full Text
- View/download PDF
6. A Preconception Paternal Fish Oil Diet Prevents Toxicant-Driven New Bronchopulmonary Dysplasia in Neonatal Mice.
- Author
-
Rumph JT, Rayford KJ, Stephens VR, Ameli S, Nde PN, Osteen KG, and Bruner-Tran KL
- Abstract
New bronchopulmonary dysplasia is a developmental lung disease associated with placental dysfunction and impaired alveolarization. Risk factors for new BPD include prematurity, delayed postnatal growth, the dysregulation of epithelial-to-mesenchymal transition (EMT), and parental exposure to toxicants. Our group previously reported that a history of paternal toxicant exposure increased the risk of prematurity and low birth weight in offspring. A history of paternal toxicant exposure also increased the offspring's risk of new BPD and disease severity was increased in offspring who additionally received a supplemental formula diet, which has also been linked to poor lung development. Risk factors associated with new BPD are well-defined, but it is unclear whether the disease can be prevented. Herein, we assessed whether a paternal fish oil diet could attenuate the development of new BPD in the offspring of toxicant exposed mice, with and without neonatal formula feeding. We investigated the impact of a paternal fish oil diet preconception because we previously reported that this intervention reduces the risk of TCDD associated placental dysfunction, prematurity, and low birth weight. We found that a paternal fish oil diet significantly reduced the risk of new BPD in neonatal mice with a history of paternal toxicant exposure regardless of neonatal diet. Furthermore, our evidence suggests that the protective effects of a paternal fish oil diet are mediated in part by the modulation of small molecules involved in EMT.
- Published
- 2021
- Full Text
- View/download PDF
7. Developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure of either parent enhances the risk of necrotizing enterocolitis in neonatal mice.
- Author
-
Mokshagundam S, Ding T, Rumph JT, Dallas M, Stephens VR, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, Animals, Newborn, Female, Humans, Infant, Newborn, Infant, Premature, Male, Mice, Parents, Enterocolitis, Necrotizing chemically induced, Polychlorinated Dibenzodioxins toxicity
- Abstract
Background: Necrotizing enterocolitis (NEC) is a rare, but potentially fatal intestinal inflammatory condition most often arising in premature infants. Infants provided formula are also at greater risk of developing this disease. Although the majority of formula-fed, preterm infants do not develop NEC, up to 30% of infants with the disease do not survive. Thus, identifying additional, currently unrecognized factors, which may predispose a specific infant to NEC development would be a significant clinical advancement. In this regard, we have previously reported that offspring of female or male mice with a history of developmental exposure to the environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exhibit altered sensitivity to inflammatory challenges and are frequently born premature. Herein, we examined the possibility that, compared to unexposed mice (F1
NONE ), developmental TCDD exposure of either parent (maternal, F1MTCDD , or paternal, F1PTCDD ) would enhance the risk of NEC in offspring (F2TCDD mice) in association with supplemental formula feeding., Methods: Beginning on postnatal day 7, all neonates were randomized to maternal milk only or maternal milk with up to 20 supplemental formula feedings. All pups remained with the Dams and were additionally allowed to nurse ad libitum., Results: Formula-fed F2NONE pups rarely developed NEC while this disease was common in formula-fed F2MTCDD and F2PTCDD mice. Unexpectedly, 50% of F2MTCDD pups that were not provided supplemental formula also developed NEC., Conclusions: Our studies provide evidence that a history of parental TCDD exposure enhances the risk of NEC in offspring and suggest exposure to environmental immunotoxicants such as TCDD may also contribute to this inflammatory disease in humans., (© 2020 Wiley Periodicals, Inc.)- Published
- 2020
- Full Text
- View/download PDF
8. Environmental Endocrine Disruptors and Endometriosis.
- Author
-
Rumph JT, Stephens VR, Archibong AE, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Endocrine Disruptors adverse effects, Endometriosis chemically induced
- Abstract
As a consequence of industrialization, thousands of man-made chemicals have been developed with few undergoing rigorous safety assessment prior to commercial use. Ubiquitous exposure to these compounds, many of which act as endocrine-disrupting chemicals (EDCs), has been suggested to be one factor in the increasing incidence of numerous diseases, including endometriosis. Endometriosis, the presence of endometrial glands and stroma outside the uterus, is a common disorder of reproductive-age women. Although a number of population-based studies have suggested that exposure to environmental EDCs may affect a woman's risk of developing this disease, results of epidemiology assessments are often equivocal. The development of endometriosis is, however, a process occurring over time; thus, a single assessment of toxicant body burden cannot definitively be linked to causation of disease. For this reason, numerous investigators have utilized a variety of rodent models to examine the impact of specific EDCs on the development of experimental endometriosis. These studies identified multiple chemicals capable of influencing physiologic processes necessary for the establishment and/or survival of ectopic tissues in rodents, suggesting that these compounds may also be of concern for women. Importantly, these models serve as useful tools to explore strategies that may prevent adverse outcomes following EDC exposure.
- Published
- 2020
- Full Text
- View/download PDF
9. Hemodynamic forces enhance decidualization via endothelial-derived prostaglandin E2 and prostacyclin in a microfluidic model of the human endometrium.
- Author
-
Gnecco JS, Ding T, Smith C, Lu J, Bruner-Tran KL, and Osteen KG
- Subjects
- Adolescent, Adult, Arterioles metabolism, Cell Differentiation physiology, Cells, Cultured, Coculture Techniques, Cyclooxygenase 2 metabolism, Decidua cytology, Female, Fibroblasts metabolism, Humans, Microfluidics methods, Middle Aged, Paracrine Communication physiology, Stromal Cells metabolism, Young Adult, Decidua blood supply, Decidua metabolism, Dinoprostone metabolism, Endothelial Cells metabolism, Epoprostenol metabolism, Hemodynamics physiology, Microfluidics instrumentation
- Abstract
Study Question: Does the uterine vasculature play a localized role in promoting stromal cell decidualization in the human endometrium?, Summary Answer: Our study demonstrated that hemodynamic forces induced secretion of specific endothelial cell-derived prostanoids that enhanced endometrial perivascular decidualization via a paracrine mechanism., What Is Known Already: Differentiation of stromal cell fibroblasts into the specialized decidua of the placenta is a progesterone-dependent process; however, histologically, it has long been noted that the first morphological signs of decidualization appear in the perivascular stroma. These observations suggest that the human endometrial vasculature plays an active role in promoting stromal differentiation., Study Design, Size, Duration: Primary human endometrial stromal cells were co-cultured for 14 days with primary uterine microvascular endothelial cells within a microfluidic Organ-on-Chip model of the endometrium., Participants/materials, Setting, Methods: Cultures were maintained with estradiol and a progestin, with or without continuous laminar perfusion to mimic hemodynamic forces derived from the blood flow. Some cultures additionally received exogenous agonist-mediated challenges. Decidualization in the microfluidic model was assessed morphologically and biochemically. ELISA was used to examine the culture effluent for expression of decidualization markers and prostaglandins. Immunofluorescence was used to monitor cyclooxygenase-2 expression in association with decidualization., Main Results and the Role of Chance: A significantly enhanced stromal decidualization response was observed in the co-cultures when the endothelial cells were stimulated with hemodynamic forces (e.g. laminar shear stress) derived from controlled microfluidic perfusion (<0.001). Furthermore, the enhanced progestin-driven stromal differentiation was mediated via cyclooxygenase-2 and the paracrine action of prostaglandin E2 and prostacyclin. Altogether, these translational findings indicate that the vascular endothelium plays a key physiologic role during the early events of perivascular decidualization in the human endometrium., Large Scale Data: N/A., Limitations, Reasons for Caution: This report is largely an in vitro study. Although we were able to experimentally mimic hemodynamic forces in our microfluidic model, we have not yet determined the contribution of additional cell types to the decidualization process or determined the precise physiological rates of shear stress that the microvasculature of the endometrium undergoes in vivo., Wider Implications of the Findings: Identification of specific endothelial-derived prostaglandins and their role during endometrial reproductive processes may have clinical utility as therapeutic targets for reproductive disorders such as infertility, endometriosis, adenomyosis, pre-eclampsia and poor pregnancy outcomes., Study Funding/competing Interest(s): This work was supported by the Veterans Affairs (I01 BX002853), the Bill and Melinda Gates Foundation Grand Challenges Exploration (OPP1159411), the Environmental Toxicology Training Grant (NIH T32 ES007028) and the Environmental Protection Agency STAR Center Grant (83573601)., Conflict of Interest: The authors report no conflicts of interest., Trial Registration Number: N/A., (© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.)
- Published
- 2019
- Full Text
- View/download PDF
10. Paternal Environmental Toxicant Exposure and Risk of Adverse Pregnancy Outcomes.
- Author
-
Bruner-Tran KL, Mokshagundam S, Barlow A, Ding T, and Osteen KG
- Abstract
Purpose of Review: Current clinical efforts to predict and prevent preterm birth are primarily focused on the mother and have made minimal progress in improving outcomes. However, recent data indicate that paternal factors can also influence timing of birth. Herein, we will review recent human and murine data examining the contribution of the father to pregnancy outcomes with an emphasis on environmental exposures that can negatively impact fertility and the timing of birth., Recent Findings: Human epidemiology studies now clearly indicate that a variety of paternal factors (age, race, weight, smoking status) can influence sperm quality, birth timing and, in some studies, offspring health. Utilizing a mouse model, our data have 57demonstrated that developmental exposure to the environmental toxicant TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is associated with a transgenerational reduction in sperm number and quality and an increased risk of preterm birth in an unexposed partner., Summary: Toxicant exposure history can clearly influence sperm quality in men and mice. Murine data further indicate that exposures which negatively affect sperm quality also impair placental function, potentially leading to preterm birth and other adverse outcomes. Of particular concern, these changes have been linked to epigenetic alterations within the male germ cell which can then be transmitted across multiple generations. Since it is not possible to prevent an ancestral toxicant exposure in a human population, identifying lifestyle modifications that can be implemented during the preconception period to improve sperm quality should be explored for the therapeutic potential to reduce the incidence of PTB and its sequelae., Competing Interests: Conflict of Interest Shilpa Mokshagundam, Alison Barlow, and Tianbing Ding declare no conflict of interest. Kaylon L. Bruner-Tran reports grants from National Institute of Environmental Health Science, the Department of Veteran Affairs, the Environmental Protection Agency, and from AMAG Pharmacueticals, during the conduct of the study. Kevin G. Osteen reports grants from Gates Foundation, the Environmental Protection Agency, the National Institute of Environmental Health Science, and from the Department of Veteran Affairs, during the conduct of the study.
- Published
- 2019
- Full Text
- View/download PDF
11. Paternal developmental toxicant exposure is associated with epigenetic modulation of sperm and placental Pgr and Igf2 in a mouse model.
- Author
-
Ding T, Mokshagundam S, Rinaudo PF, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, DNA (Cytosine-5-)-Methyltransferases genetics, DNA Methylation, Disease Models, Animal, Endocrine Disruptors toxicity, Female, Fetal Growth Retardation etiology, Insulin-Like Growth Factor II deficiency, Insulin-Like Growth Factor II metabolism, Male, Mice, Mice, Inbred C57BL, Placentation genetics, Polychlorinated Dibenzodioxins toxicity, Pregnancy, RNA, Messenger genetics, RNA, Messenger metabolism, Receptors, Progesterone deficiency, Receptors, Progesterone metabolism, Epigenesis, Genetic drug effects, Insulin-Like Growth Factor II genetics, Paternal Exposure adverse effects, Placenta metabolism, Receptors, Progesterone genetics, Spermatozoa metabolism
- Abstract
Preterm birth (PTB), parturition prior to 37 weeks' gestation, is the leading cause of neonatal mortality. The causes of spontaneous PTB are poorly understood; however, recent studies suggest that this condition may arise as a consequence of the parental fetal environment. Specifically, we previously demonstrated that developmental exposure of male mice (F1 animals) to the environmental endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was associated with reduced sperm quantity/quality in adulthood and control female partners frequently delivered preterm. Reproductive defects persisted in the F2 and F3 descendants, and spontaneous PTB was common. Reproductive changes in the F3 males, the first generation without direct TCDD exposure, suggest the occurrence of epigenetic alterations in the sperm, which have the potential to impact placental development. Herein, we conducted an epigenetic microarray analysis of control and F1 male-derived placentae, which identified 2171 differentially methylated regions, including the progesterone receptor (Pgr) and insulin-like growth factor (Igf2). To assess if Pgr and Igf2 DNA methylation changes were present in sperm and persist in future generations, we assessed methylation and expression of these genes in F1/F3 sperm and F3-derived placentae. Although alterations in methylation and gene expression were observed, in most tissues, only Pgr reached statistical significance. Despite the modest gene expression changes in Igf2, offspring of F1 and F3 males consistently exhibited IUGR. Taken together, our data indicate that paternal developmental TCDD exposure is associated with transgenerational placental dysfunction, suggesting epigenetic modifications within the sperm have occurred. An evaluation of additional genes and alternative epigenetic mechanisms is warranted.
- Published
- 2018
- Full Text
- View/download PDF
12. Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.
- Author
-
Bruner-Tran KL, Mokshagundam S, Herington JL, Ding T, and Osteen KG
- Abstract
Background: Although it has been more than a century since endometriosis was initially described in the literature, understanding the etiology and natural history of the disease has been challenging. However, the broad utility of murine and rat models of experimental endometriosis has enabled the elucidation of a number of potentially targetable processes which may otherwise promote this disease., Objective: To review a variety of studies utilizing rodent models of endometriosis to illustrate their utility in examining mechanisms associated with development and progression of this disease., Results: Use of rodent models of endometriosis has provided a much broader understanding of the risk factors for the initial development of endometriosis, the cellular pathology of the disease and the identification of potential therapeutic targets., Conclusion: Although there are limitations with any animal model, the variety of experimental endometriosis models that have been developed has enabled investigation into numerous aspects of this disease. Thanks to these models, our under-standing of the early processes of disease development, the role of steroid responsiveness, inflammatory processes and the peritoneal environment has been advanced. More recent models have begun to shed light on how epigenetic alterations con-tribute to the molecular basis of this disease as well as the multiple comorbidities which plague many patients. Continued de-velopments of animal models which aid in unraveling the mechanisms of endometriosis development provide the best oppor-tunity to identify therapeutic strategies to prevent or regress this enigmatic disease.
- Published
- 2018
- Full Text
- View/download PDF
13. Sex-Dependent Influence of Developmental Toxicant Exposure on Group B Streptococcus-Mediated Preterm Birth in a Murine Model.
- Author
-
Ding T, Lambert LA, Aronoff DM, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, Disease Models, Animal, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, Placenta drug effects, Placenta metabolism, Placenta microbiology, Pregnancy, Maternal Exposure, Paternal Exposure, Polychlorinated Dibenzodioxins toxicity, Premature Birth chemically induced, Premature Birth microbiology, Streptococcal Infections complications
- Abstract
Infectious agents are a significant risk factor for preterm birth (PTB); however, the simple presence of bacteria is not sufficient to induce PTB in most women. Human and animal data suggest that environmental toxicant exposures may act in concert with other risk factors to promote PTB. Supporting this "second hit" hypothesis, we previously demonstrated exposure of fetal mice (F1 animals) to the environmental endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads to an increased risk of spontaneous and infection-mediated PTB in adult animals. Surprisingly, adult F1
males also confer an enhanced risk of PTB to their control partners. Herein, we used a recently established model of ascending group B Streptococcus (GBS) infection to explore the impact of a maternal versus paternal developmental TCDD exposure on infection-mediated PTB in adulthood. Group B Streptococcus is an important contributor to PTB in women and can have serious adverse effects on their infants. Our studies revealed that although gestation length was reduced in control mating pairs exposed to low-dose GBS, dams were able to clear the infection and bacterial transmission to pups was minimal. In contrast, exposure of pregnant F1females to the same GBS inoculum resulted in 100% maternal and fetal mortality. Maternal health and gestation length were not impacted in control females mated to F1males and exposed to GBS; however, neonatal survival was reduced compared to controls. Our data revealed a sex-dependent impact of parental TCDD exposure on placental expression of Toll-like receptor 2 and glycogen production, which may be responsible for the differential impact on fetal and maternal outcomes in response to GBS infection.- Published
- 2018
- Full Text
- View/download PDF
14. Therapeutically Targeting the Inflammasome Product in a Chimeric Model of Endometriosis-Related Surgical Adhesions.
- Author
-
Stocks MM, Crispens MA, Ding T, Mokshagundam S, Bruner-Tran KL, and Osteen KG
- Subjects
- Animals, Disease Models, Animal, Endometriosis pathology, Endometrium pathology, Endometrium transplantation, Female, Mice, Tissue Adhesions drug therapy, Endometriosis metabolism, Endometrium metabolism, Inflammasomes metabolism, Interleukin 1 Receptor Antagonist Protein therapeutic use, Tissue Adhesions metabolism
- Abstract
Development of adhesions commonly occurs in association with surgery for endometriosis. Even in the absence of surgery, women with endometriosis appear to be at an enhanced risk of developing adhesions. In the current study, we utilized a chimeric mouse model of experimental endometriosis in order to examine the role of inflammasome activation in the development of postsurgical adhesions. Mice were randomized to receive peritoneal injections of human endometrial tissue fragments or endometrial tissue conditioned media (CM) from women with or without endometriosis 16 hours after ovariectomy and placement of an estradiol-releasing silastic capsule. A subset of mice receiving CM was also treated with interleukin (IL) 1 receptor antagonist (IL-1ra). Our studies demonstrate that peritoneal injection of endometrial tissue fragments near the time of surgery resulted in extensive adhesive disease regardless of tissue origin. However, adhesion scores were significantly higher in mice receiving CM from tissues acquired from patients with endometriosis compared to control tissue CM ( P = .0001). Cytokine bead array analysis of endometrial CM revealed enhanced expression of IL-1β from patients with endometriosis compared to controls ( P < .01). Finally, the ability of human tissue CM to promote adhesive disease was dramatically reduced in mice cotreated with IL-1ra ( P < .0001). Our data implicate enhanced expression of IL-1β in women with endometriosis as a potential causal factor in their increased susceptibility of developing postsurgical adhesions. Thus, targeting inflammasome activation may be an effective strategy for the prevention of surgical adhesions in patients with endometriosis.
- Published
- 2017
- Full Text
- View/download PDF
15. Compartmentalized Culture of Perivascular Stroma and Endothelial Cells in a Microfluidic Model of the Human Endometrium.
- Author
-
Gnecco JS, Pensabene V, Li DJ, Ding T, Hui EE, Bruner-Tran KL, and Osteen KG
- Subjects
- Cell Culture Techniques, Endometrium cytology, Female, Human Umbilical Vein Endothelial Cells cytology, Humans, Porosity, Endometrium blood supply, Endometrium metabolism, Human Umbilical Vein Endothelial Cells metabolism, Membranes, Artificial, Models, Cardiovascular, Tissue Engineering methods
- Abstract
The endometrium is the inner lining of the uterus. Following specific cyclic hormonal stimulation, endometrial stromal fibroblasts (stroma) and vascular endothelial cells exhibit morphological and biochemical changes to support embryo implantation and regulate vascular function, respectively. Herein, we integrated a resin-based porous membrane in a dual chamber microfluidic device in polydimethylsiloxane that allows long term in vitro co-culture of human endometrial stromal and endothelial cells. This transparent, 2-μm porous membrane separates the two chambers, allows for the diffusion of small molecules and enables high resolution bright field and fluorescent imaging. Within our primary human co-culture model of stromal and endothelial cells, we simulated the temporal hormone changes occurring during an idealized 28-day menstrual cycle. We observed the successful differentiation of stroma into functional decidual cells, determined by morphology as well as biochemically as measured by increased production of prolactin. By controlling the microfluidic properties of the device, we additionally found that shear stress forces promoted cytoskeleton alignment and tight junction formation in the endothelial layer. Finally, we demonstrated that the endometrial perivascular stroma model was sustainable for up to 4 weeks, remained sensitive to steroids and is suitable for quantitative biochemical analysis. Future utilization of this device will allow the direct evaluation of paracrine and endocrine crosstalk between these two cell types as well as studies of immunological events associated with normal vs. disease-related endometrial microenvironments.
- Published
- 2017
- Full Text
- View/download PDF
16. Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.
- Author
-
Bruner-Tran KL, Gnecco J, Ding T, Glore DR, Pensabene V, and Osteen KG
- Subjects
- Animals, Endometriosis chemically induced, Endometriosis genetics, Epigenesis, Genetic drug effects, Female, Humans, Male, Mice, Reproduction genetics, Endocrine Disruptors toxicity, Environmental Exposure adverse effects, Polychlorinated Dibenzodioxins toxicity, Reproduction drug effects
- Abstract
Humans and other animals are exposed to a wide array of man-made toxicants, many of which act as endocrine disruptors that exhibit differential effects across the lifespan. In humans, while the impact of adult exposure is known for some compounds, the potential consequences of developmental exposure to endocrine disrupting chemicals (EDCs) is more difficult to ascertain. Animal studies have revealed that exposure to EDCs prior to puberty can lead to adult reproductive disease and dysfunction. Specifically, in adult female mice with an early life exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), we demonstrated a transgenerational occurrence of several reproductive diseases that have been linked to endometriosis in women. Herein, we review the evidence for TCDD-associated development of adult reproductive disease as well as known epigenetic alterations associated with TCDD and/or endometriosis. We will also introduce new "Organ-on-Chip" models which, combined with our established murine model, are expected to further enhance our ability to examine alterations in gene-environment interactions that lead to heritable disease., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
17. Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model.
- Author
-
Bruner-Tran KL, Duleba AJ, Taylor HS, and Osteen KG
- Abstract
The common environmental toxicant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or, commonly, dioxin) is a known endocrine disruptor that has been linked to the development of endometriosis in experimental models. Using a murine model, we previously demonstrated that in utero TCDD exposure promotes the transgenerational development of an "endometriosis-like" uterine phenotype consisting of reduced responsiveness to progesterone, subfertility and an increased risk of preterm birth. Since adenomyosis is frequently observed as a comorbidity in women with endometriosis, herein, we sought to determine the incidence of adenomyosis in non-pregnant mice with a history of direct or indirect TCDD exposure. Using histologic assessment and immunohistochemical staining, we analyzed murine uteri for adenomyosis, microvessel density and expression of estrogen receptors alpha and beta (ESR1 and ESR2). Our studies revealed that unexposed control mice did not exhibit adenomyosis while this disease was frequently observed in mice with a history of early life TCDD exposure. A transgenerational impact of developmental TCDD exposure was demonstrated since a subset of mice with only an indirect exposure (F3) also exhibited adenomyosis. Microvessel density within the uterus was significantly higher in all groups of TCDD exposed mice compared to control animals, with density correlated to the severity of disease. Both ESR1 and ESR2 protein exhibited alterations in expression in experimental mice compared to controls. Similar to women with endometriosis, we observed a significant reduction in the ratio of Esr1/Esr2 mRNA in all F1 mice compared to controls. Although this retrospective study was not designed to specifically address mechanisms associated with development of adenomyosis, our data suggest that developmental TCDD exposure permanently alters adult steroid responses which may contribute to the transgenerational development of adenomyosis., (Copyright 2016 by The Society for the Study of Reproduction.)
- Published
- 2016
- Full Text
- View/download PDF
18. Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.
- Author
-
Palmer SS, Altan M, Denis D, Tos EG, Gotteland JP, Osteen KG, Bruner-Tran KL, and Nataraja SG
- Subjects
- Adult, Animals, Benzothiazoles pharmacology, Cytokines metabolism, Disease Models, Animal, Endometriosis metabolism, Endometrium metabolism, Enzyme Inhibitors pharmacology, Female, Humans, Killer Cells, Natural drug effects, Killer Cells, Natural metabolism, MAP Kinase Signaling System drug effects, Matrix Metalloproteinase 3 metabolism, Medroxyprogesterone Acetate pharmacology, Medroxyprogesterone Acetate therapeutic use, Mice, Mice, Nude, Progesterone pharmacology, Progesterone therapeutic use, Pyrimidines pharmacology, Rats, Benzothiazoles therapeutic use, Endometriosis drug therapy, Endometrium drug effects, Enzyme Inhibitors therapeutic use, JNK Mitogen-Activated Protein Kinases antagonists & inhibitors, Pyrimidines therapeutic use
- Abstract
Endometriosis is an estrogen (ER)-dependent gynecological disease caused by the growth of endometrial tissue at extrauterine sites. Current endocrine therapies address the estrogenic aspect of disease and offer some relief from pain but are associated with significant side effects. Immune dysfunction is also widely believed to be an underlying contributor to the pathogenesis of this disease. This study evaluated an inhibitor of c-Jun N-terminal kinase, bentamapimod (AS602801), which interrupts immune pathways, in 2 rodent endometriosis models. Treatment of nude mice bearing xenografts biopsied from women with endometriosis (BWE) with 30 mg/kg AS602801 caused 29% regression of lesion. Medroxyprogesterone acetate (MPA) or progesterone (PR) alone did not cause regression of BWE lesions, but combining 10 mg/kg AS602801 with MPA caused 38% lesion regression. In human endometrial organ cultures (from healthy women), treatment with AS602801 or MPA reduced matrix metalloproteinase-3 (MMP-3) release into culture medium. In organ cultures established with BWE, PR or MPA failed to inhibit MMP-3 secretion, whereas AS602801 alone or MPA + AS602801 suppressed MMP-3 production. In an autologous rat endometriosis model, AS602801 caused 48% regression of lesions compared to GnRH antagonist Antide (84%). AS602801 reduced inflammatory cytokines in endometriotic lesions, while levels of cytokines in ipsilateral horns were unaffected. Furthermore, AS602801 enhanced natural killer cell activity, without apparent negative effects on uterus. These results indicate that bentamapimod induced regression of endometriotic lesions in endometriosis rodent animal models without suppressing ER action. c-Jun N-terminal kinase inhibition mediated a comprehensive reduction in cytokine secretion and moreover was able to overcome PR resistance., (© The Author(s) 2015.)
- Published
- 2016
- Full Text
- View/download PDF
19. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
- Author
-
Arosh JA, Lee J, Balasubbramanian D, Stanley JA, Long CR, Meagher MW, Osteen KG, Bruner-Tran KL, Burghardt RC, Starzinski-Powitz A, and Banu SK
- Subjects
- Animals, Apoptosis drug effects, Biphenyl Compounds pharmacology, Biphenyl Compounds therapeutic use, Caspase 3 metabolism, Cell Line, Cell Movement drug effects, Cell Survival drug effects, Disease Models, Animal, Endometrium blood supply, Endometrium pathology, Estrogens biosynthesis, Female, Humans, Inflammation pathology, Mice, Neovascularization, Pathologic metabolism, Neovascularization, Pathologic pathology, Pelvic Pain drug therapy, Pelvic Pain pathology, Poly(ADP-ribose) Polymerases metabolism, Progesterone metabolism, Signal Transduction drug effects, Steroids therapeutic use, Xanthones pharmacology, Xanthones therapeutic use, Endometriosis drug therapy, Endometriosis pathology, Receptors, Prostaglandin E, EP2 Subtype antagonists & inhibitors, Receptors, Prostaglandin E, EP4 Subtype antagonists & inhibitors
- Abstract
Endometriosis is a debilitating, estrogen-dependent, progesterone-resistant, inflammatory gynecological disease of reproductive age women. Two major clinical symptoms of endometriosis are chronic intolerable pelvic pain and subfertility or infertility, which profoundly affect the quality of life in women. Current hormonal therapies to induce a hypoestrogenic state are unsuccessful because of undesirable side effects, reproductive health concerns, and failure to prevent recurrence of disease. There is a fundamental need to identify nonestrogen or nonsteroidal targets for the treatment of endometriosis. Peritoneal fluid concentrations of prostaglandin E2 (PGE2) are higher in women with endometriosis, and this increased PGE2 plays important role in survival and growth of endometriosis lesions. The objective of the present study was to determine the effects of pharmacological inhibition of PGE2 receptors, EP2 and EP4, on molecular and cellular aspects of the pathogenesis of endometriosis and associated clinical symptoms. Using human fluorescent endometriotic cell lines and chimeric mouse model as preclinical testing platform, our results, to our knowledge for the first time, indicate that selective inhibition of EP2/EP4: (i) decreases growth and survival of endometriosis lesions; (ii) decreases angiogenesis and innervation of endometriosis lesions; (iii) suppresses proinflammatory state of dorsal root ganglia neurons to decrease pelvic pain; (iv) decreases proinflammatory, estrogen-dominant, and progesterone-resistant molecular environment of the endometrium and endometriosis lesions; and (v) restores endometrial functional receptivity through multiple mechanisms. Our novel findings provide a molecular and preclinical basis to formulate long-term nonestrogen or nonsteroidal therapy for endometriosis.
- Published
- 2015
- Full Text
- View/download PDF
20. Developmental exposure of mice to dioxin promotes transgenerational testicular inflammation and an increased risk of preterm birth in unexposed mating partners.
- Author
-
Bruner-Tran KL, Ding T, Yeoman KB, Archibong A, Arosh JA, and Osteen KG
- Subjects
- Animals, Environmental Pollutants adverse effects, Female, Infertility, Male complications, Infertility, Male pathology, Inflammation complications, Inflammation pathology, Male, Mice, Mice, Inbred C57BL, Pregnancy, Prenatal Exposure Delayed Effects pathology, Spermatozoa drug effects, Spermatozoa pathology, Testis pathology, Endocrine Disruptors adverse effects, Infertility, Male chemically induced, Inflammation chemically induced, Polychlorinated Dibenzodioxins adverse effects, Premature Birth chemically induced, Prenatal Exposure Delayed Effects chemically induced, Testis drug effects
- Abstract
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, commonly known as dioxin) is a ubiquitous environmental contaminant and known endocrine disruptor. Using a mouse model, we previously found that adult female mice exposed in utero to TCDD (F1 generation) as well as multiple subsequent generations (F2-F4) exhibited reduced fertility and an increased incidence of spontaneous preterm birth. Additional studies revealed that male F1 mice with a similar in utero/developmental TCDD exposure also exhibited diminished fertility and conferred an increased risk of preterm birth to their unexposed mating partners. Herein, we extend these previous observations, reporting that reduced fertility in male F1 mice is linked to testicular inflammation which coincides with apoptosis of developing spermatocytes, sub-fertility and an increased risk of preterm birth in their unexposed mating partners. Significantly, in the absence of additional toxicant exposure, testicular inflammation and reduced fertility persisted in F2 and F3 males and their control mating partners also frequently exhibited spontaneous preterm birth. Although a steady, global decline in male fertility has been noted over the last few decades, the reasons for these changes have not been firmly established. Likewise, the PTB rate in the U.S. and other countries has paralleled industrial development, suggesting a possible relationship between environmental toxicant exposure and adverse pregnancy outcomes. Most current clinical strategies to prevent preterm birth are focused solely on the mother and have yielded limited benefits. In contrast, our studies strongly suggest that the preconception testicular health of the father is a critical determinant of pregnancy outcomes in mice. Future clinical studies should examine the potential contribution of the male to gestation length in women and whether efforts to reduce the incidence of preterm birth should be initiated in both parents prior to pregnancy.
- Published
- 2014
- Full Text
- View/download PDF
21. Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology.
- Author
-
Bruner-Tran KL, Herington JL, Duleba AJ, Taylor HS, and Osteen KG
- Subjects
- Animals, Endometriosis drug therapy, Endometriosis genetics, Endometriosis immunology, Endometrium physiology, Female, Forecasting, Genital Diseases, Female drug therapy, Genital Diseases, Female genetics, Genotype, Humans, Progesterone physiology, Endometriosis complications, Endometriosis physiopathology, Genital Diseases, Female complications, Genital Diseases, Female immunology, Inflammation complications, Inflammation physiopathology
- Abstract
Progesterone action normally mediates the balance between anti-inflammatory and proinflammatory processes throughout the female reproductive tract. However, in women with endometriosis, endometrial progesterone resistance, characterized by alterations in progesterone responsive gene and protein expression, is now considered a central element in disease pathophysiology. Recent studies additionally suggest that the peritoneal microenvironment of endometriosis patients exhibits altered physiological characteristics that may further promote inflammation-driven disease development and progression. Within this review, we summarize our current understanding of the pathogenesis of endometriosis with an emphasis on the role that inflammation plays in generating not only the progesterone-resistant eutopic endometrium but also a peritoneal microenvironment that may contribute significantly to disease establishment. Viewing endometriosis from the emerging perspective that a progesterone resistant endometrium and an immunologically compromised peritoneal microenvironment are biologically linked risk factors for disease development provides a novel mechanistic framework to identify new therapeutic targets for appropriate medical management.
- Published
- 2013
22. Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.
- Author
-
Sokalska A, Anderson M, Villanueva J, Ortega I, Bruner-Tran KL, Osteen KG, and Duleba AJ
- Subjects
- Adult, Animals, Apoptosis drug effects, Apoptosis physiology, Cell Proliferation drug effects, Cell Survival drug effects, Cell Survival physiology, Chimera, Disease Models, Animal, Endometriosis pathology, Fatty Acid-Binding Proteins genetics, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Membrane Proteins genetics, Mice, Mice, Nude, Neoplasm Proteins genetics, Primary Cell Culture, Receptors, Retinoic Acid genetics, Stromal Cells cytology, Stromal Cells metabolism, Endometriosis drug therapy, Endometriosis metabolism, Endometrium cytology, Simvastatin pharmacology, Stromal Cells drug effects, Tretinoin metabolism
- Abstract
Context: Retinoic acid (RA) may promote survival or apoptosis of cells, depending on the levels of binding proteins: apoptosis-inducing cellular RA binding protein 2 (CRABP2), and cell survival-promoting fatty acid binding protein 5 (FABP5). Increased cellular uptake of retinol and altered actions of RA related to reduced expression of CRABP2 may contribute to the development of endometriosis. Recently statins have been shown to inhibit growth of human endometrial stromal (HES) cells and to reduce the number and size of endometriotic implants in experimental models of this disorder., Objective: The objective of the study was to determine whether effects of simvastatin on HES cells and experimental endometriotic implants are related to the modulation of the RA system., Methods: Effects of simvastatin and RA on proliferation and apoptosis of HES cells were evaluated. Expression of stimulated by RA 6 (STRA6), CRABP2, and FABP5 was determined by real-time PCR and Western blotting. Effects of simvastatin were also evaluated in a nude mouse model of human endometriosis., Results: Simvastatin potentiated an inhibitory effect of RA on growth of HES cells. In HES cells, simvastatin induced expression of STRA6 and CRABP2 but not FABP5. Similarly, simvastatin treatment of nude mice bearing human endometrial xenografts led to an increased expression of CRABP2 and STRA6 proteins in ectopic lesions., Conclusions: Simvastatin interacts with the RA system, inducing the expression of the key protein regulating the uptake of retinol (STRA6) and the expression of apoptosis-promoting CRABP2. These effects may contribute to cooperative apoptosis-inducing effects of simvastatin and RA and support the examination of these compounds in the treatment of endometriosis.
- Published
- 2013
- Full Text
- View/download PDF
23. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
- Author
-
Villanueva JA, Sokalska A, Cress AB, Ortega I, Bruner-Tran KL, Osteen KG, and Duleba AJ
- Subjects
- Acetates metabolism, Adult, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Carbon Radioisotopes, Cholesterol biosynthesis, Cholesterol metabolism, Drug Synergism, Female, Gene Expression Regulation, Enzymologic drug effects, Humans, Hydroxymethylglutaryl CoA Reductases genetics, Hydroxymethylglutaryl CoA Reductases metabolism, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Primary Cell Culture, RNA, Messenger metabolism, Resveratrol, Stromal Cells cytology, Endometrium cytology, Mevalonic Acid metabolism, Simvastatin pharmacology, Stilbenes pharmacology, Stromal Cells drug effects, Stromal Cells metabolism
- Abstract
Context: Growth of endometriotic lesions in rodent model of endometriosis is inhibited by resveratrol, a natural polyphenol with antiproliferative and antiinflammatory properties, and simvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) activity., Objective: The objective of the investigation was to study the mechanism of action of resveratrol and its interactions with simvastatin, focusing on cholesterol biosynthesis and HMGCR gene expression and protein activity in primary cultures of human endometrial stromal (HES) cells., Methods: HES cells were obtained from healthy volunteers. Biosynthesis of cholesterol was assessed by measuring the conversion of [(14)C]acetate to [(14)C]cholesterol. HMGCR mRNA transcripts were quantified by real-time PCR, protein expression by Western blot analysis, and enzyme activity by measuring the conversion of [3-(14)C]3-hydroxy-3-methyl-glutaryl-coenzyme A to [(14)C]mevalonic acid lactone in HES cell microsomes., Results: Resveratrol inhibited cholesterol biosynthesis, HMGCR mRNA, and enzyme activity. Simvastatin inhibited cholesterol biosynthesis and enzyme activity but increased HMGCR mRNA and protein expression. Resveratrol potentiated the inhibitory effects of simvastatin on cholesterol biosynthesis and HMGCR enzyme activity and abrogated the stimulatory effects of simvastatin on HMGCR mRNA transcripts and protein expression., Conclusions: Resveratrol inhibits key steps of the mevalonate pathway by mechanisms that are partly complementary to and partly comparable with simvastatin via reducing both expression and activity of HMGCR. A combination of resveratrol and simvastatin may be of potential clinical relevance to development new treatments of human endometriosis.
- Published
- 2013
- Full Text
- View/download PDF
24. Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model.
- Author
-
Herington JL, Glore DR, Lucas JA, Osteen KG, and Bruner-Tran KL
- Subjects
- Administration, Oral, Adult, Animals, Endometriosis drug therapy, Female, Humans, Mice, Mice, Nude, Middle Aged, Dietary Fats, Unsaturated administration & dosage, Dietary Supplements, Disease Models, Animal, Endometriosis pathology, Endometriosis prevention & control, Fish Oils administration & dosage
- Abstract
Objective: To examine whether dietary fish oil supplementation reduces development of spontaneous endometriosis-associated adhesions using an established model., Design: Laboratory-based study., Setting: Medical center research laboratory. PATIENT(S)/ANIMAL(S): Disease-free women of reproductive age and nude mice., Intervention(s): Women were not provided any intervention. Mice were randomized to receive fish oil supplementation or control diet., Main Outcome Measure(s): Experimental endometriosis was established in mice via injection of human endometrial tissue within 16 hours of ovariectomy. Mice were provided standard or menhaden fish oil-supplemented diets for ≥ 2 weeks before initiation of experimental endometriosis and until killing them 1 week later. At necropsy, mice were examined for the presence and extent of adhesions and endometriotic-like lesions. Tissues were excised and morphologically characterized., Result(s): Adhesions/lesions were reduced in mice provided with dietary fish oil compared with control animals. Leukocytes were more numerous within the adhesions/lesions of the mice maintained on the standard diet compared with animals provided with fish oil. As indicated by staining intensity, collagen deposition was greater at adhesion sites within control mice compared with fish oil-supplemented animals., Conclusion(s): Wound-healing associated with surgery created an inflammatory peritoneal microenvironment that promoted the development of both experimental endometriosis and adhesions in a murine model. Targeting excessive inflammation with fish oil may be an effective adjuvant therapy to reduce the development of postsurgical adhesions related to endometriosis., (Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
25. Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
- Author
-
Resuehr D, Glore DR, Taylor HS, Bruner-Tran KL, and Osteen KG
- Subjects
- Adolescent, Adult, Biopsy, Cell Differentiation drug effects, Cell Differentiation physiology, Cells, Cultured, Endometriosis metabolism, Endometriosis pathology, Endometrium pathology, Environmental Pollutants toxicity, Female, Gene Expression drug effects, Gene Expression physiology, Gonanes pharmacology, Hormone Antagonists pharmacology, Humans, Interleukin-1alpha pharmacology, Middle Aged, Receptor, Cannabinoid, CB1 metabolism, Stromal Cells drug effects, Stromal Cells pathology, Stromal Cells physiology, Young Adult, Endometriosis physiopathology, Endometrium metabolism, Polychlorinated Dibenzodioxins toxicity, Progesterone metabolism, Receptor, Cannabinoid, CB1 genetics
- Abstract
Objective: To examine the differentiation-related expression of cannabinoid receptor type 1 (CB1-R) messenger RNA (mRNA) and protein in endometrial tissue obtained from women with and without endometriosis and to determine the impact of acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure on CB1-R gene expression in isolated endometrial stromal cells., Design: Laboratory-based study., Setting: University-affiliated medical center., Patient(s): Women with and without endometriosis undergoing volunteer endometrial biopsies after informed consent., Intervention(s): None., Main Outcome Measure(s): Analysis of in vivo CB1-R mRNA and protein expression in human endometrial tissues and mRNA expression in isolated stromal cells after exposure to TCDD or a progesterone receptor antagonist (onapristone)., Result(s): Expression of CB1-R mRNA and protein was highest during the progesterone-dominated secretory phase in control samples, but expression was minimal in the endometrial tissues acquired from women with endometriosis, regardless of the cycle phase. Although progesterone was found to induce CB1-R mRNA expression in endometrial stromal cells from control donors, steroid-induced expression of this gene was inhibited by cotreatment with either TCDD or onapristone., Conclusion(s): Our studies reveal a role for the anti-inflammatory actions of progesterone in regulating endometrial cannabinoid signaling, which is disrupted in women with endometriosis. We demonstrate for the first time that acute TCDD exposure disrupts cannabinoid signaling in the human endometrium., (Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
26. The Role of Endocrine Disruptors in the Epigenetics of Reproductive Disease and Dysfunction: Potential Relevance to Humans.
- Author
-
Bruner-Tran KL, Resuehr D, Ding T, Lucas JA, and Osteen KG
- Abstract
In a murine model, we have linked early life toxicant exposure to reduced uterine sensitivity to progesterone, a phenotype we had previously associated with inflammation in endometriosis patients. Subsequent studies revealed that developmental toxicant exposure not only reduces fertility in male and female mice but also negatively impacts pregnancy leading to spontaneous preterm birth (PTB). An epigenetic alteration of the progesterone receptor gene correlated with reduced fertility and adverse pregnancy outcomes and persisted in multiple generations of mice in the absence of an additional toxicant exposure. Gene-environment interactions in women may explain why some patients "at risk" for PTB deliver at term while others without known risks deliver early. Our model provides a unique system to unravel the interactive influences of inflammation and reduced progesterone responsiveness on PTB and suggests that therapy needs to begin prior to pregnancy (and involve both partners) rather than once the inflammatory cascade has been initiated.
- Published
- 2012
- Full Text
- View/download PDF
27. Simvastatin decreases invasiveness of human endometrial stromal cells.
- Author
-
Sokalska A, Cress A, Bruner-Tran KL, Osteen KG, Taylor HS, Ortega I, and Duleba AJ
- Subjects
- Animals, Cell Adhesion drug effects, Endometriosis genetics, Endometriosis metabolism, Endometriosis pathology, Endometrium metabolism, Endometrium pathology, Female, Gene Expression drug effects, Humans, Hyaluronan Receptors genetics, Hyaluronan Receptors metabolism, Matrix Metalloproteinase 2 genetics, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 3 genetics, Matrix Metalloproteinase 3 metabolism, Mice, Mice, Nude, Polyisoprenyl Phosphates metabolism, Polyisoprenyl Phosphates pharmacology, Prenylation drug effects, Sesquiterpenes metabolism, Sesquiterpenes pharmacology, Stromal Cells drug effects, Stromal Cells metabolism, Stromal Cells pathology, Tissue Inhibitor of Metalloproteinase-2 genetics, Tissue Inhibitor of Metalloproteinase-2 metabolism, Endometriosis drug therapy, Endometrium drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Simvastatin pharmacology
- Abstract
Recently we reported that statins, the competitive inhibitors of the key enzyme regulating the mevalonate pathway, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), decrease proliferation of human endometrial stromal (HES) cells. Furthermore, we found that simvastatin treatment reduces the number and the size of endometrial implants in a nude mouse model of endometriosis. The present study was undertaken to investigate the effect of simvastatin on HES cell invasiveness and on expression of selected genes relevant to invasiveness: matrix metalloproteinase 2 (MMP2), MMP3, tissue inhibitor of matrix metalloproteinase 2 (TIMP2), and CD44. Because statin-induced inhibition of HMGCR reduces the production of substrates for isoprenylation-geranylgeranyl pyrophosphate (GGPP) and farnesyl pyrophosphate (FPP)-the effects of GGPP and FPP were also evaluated. Simvastatin induced a concentration-dependent reduction of invasiveness of HES cells. This effect of simvastatin was abrogated by GGPP but not by FPP. Simvastatin also reduced the mRNA levels of MMP2, MMP3, and CD44, but increased TIMP2 mRNA; all these effects of simvastatin were partly or entirely reversed in the presence of GGPP. The present findings provide a novel mechanism of action of simvastatin on endometrial stroma that may explain reduction of endometriosis in animal models of this disease. Furthermore, the presently described effects of simvastatin are likely mediated, at least in part, by inhibition of geranylgeranylation.
- Published
- 2012
- Full Text
- View/download PDF
28. Novel therapies targeting endometriosis.
- Author
-
Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, and Duleba AJ
- Subjects
- Angiogenesis Inhibitors therapeutic use, Animals, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Selective Estrogen Receptor Modulators therapeutic use, Endometriosis drug therapy
- Abstract
Endometriosis is an often painful disorder in which the endometrial glands and stroma grow outside the uterus. The disease affects women's quality of life and is a common cause of infertility. In this review, we describe promising new developments in the field based on in vitro assays and rodent models, each of which has the potential to be beneficial in the treatment of this disease. We will specifically describe the role of anti-inflammatory drugs, selective estrogen, or progesterone modulators, statins, antiangiogenic agents, and the potential for targeting stem cells as likely methods to hone in and eliminate endometriosis. The most promising of these potential therapies are currently slated for further testing in both rodent and nonhuman primate trials.
- Published
- 2011
- Full Text
- View/download PDF
29. Immune interactions in endometriosis.
- Author
-
Herington JL, Bruner-Tran KL, Lucas JA, and Osteen KG
- Subjects
- Animals, Endometriosis etiology, Endometriosis pathology, Endometriosis therapy, Environmental Exposure adverse effects, Female, Humans, Immunologic Surveillance drug effects, Immunologic Surveillance immunology, Polychlorinated Dibenzodioxins adverse effects, Progesterone immunology, Teratogens toxicity, Endometriosis immunology
- Abstract
Endometriosis is a common, complex gynecologic disorder characterized by the presence of endometrial glands and stroma at extrauterine (ectopic) sites. In women who develop this disease, alterations in specific biological processes involving both the endocrine and immune systems have been observed, which may explain the survival and growth of displaced endometrial tissue in affected women. In the past decade, a considerable amount of research has implicated a role for alterations in progesterone action at both eutopic and ectopic sites of endometrial growth which may contribute to the excessive inflammation associated with progression of endometriosis; however, it remains unclear whether these anomalies induce the condition or are simply a consequence of the disease process. In this article, we summarize current knowledge of alterations within the immune system of endometriosis patients and discuss how endometrial cells from women with this disease not only have the capacity to escape immunosurveillance, but also use inflammatory mechanisms to promote their growth within the peritoneal cavity. Finally, we discuss evidence that exposure to an environmental endocrine disruptor, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, can mediate the development of an endometrial phenotype that exhibits both reduced progesterone responsiveness and hypersensitivity to proinflammatory stimuli mimicking the endometriosis phenotype. Future studies in women with endometriosis should consider whether a heightened inflammatory response within the peritoneal microenvironment contributes to the development and persistence of this disease.
- Published
- 2011
- Full Text
- View/download PDF
30. Preconception omega-3 fatty acid supplementation of adult male mice with a history of developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure prevents preterm birth in unexposed female partners.
- Author
-
McConaha ME, Ding T, Lucas JA, Arosh JA, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, Female, Fish Oils therapeutic use, Gene Expression Regulation, Developmental drug effects, Hydroxyprostaglandin Dehydrogenases genetics, Hydroxyprostaglandin Dehydrogenases metabolism, Male, Mice, Mice, Inbred C57BL, Placenta drug effects, Placenta immunology, Placenta metabolism, Placenta pathology, Pregnancy, Pregnancy Proteins genetics, Pregnancy Proteins metabolism, Premature Birth chemically induced, Premature Birth immunology, RNA, Messenger metabolism, Receptors, Progesterone genetics, Receptors, Progesterone metabolism, Spermatogenesis drug effects, Toll-Like Receptor 4 genetics, Toll-Like Receptor 4 metabolism, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Dietary Supplements, Environmental Pollutants toxicity, Fatty Acids, Omega-3 therapeutic use, Paternal Exposure, Polychlorinated Dibenzodioxins toxicity, Premature Birth prevention & control
- Abstract
We have recently reported that adult male C57BL/6 mice exposed in utero to the environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) confer an increased risk of preterm birth (PTB) to unexposed females. Risk of PTB was coincident with decreased placental progesterone receptor (Pgr) mRNA expression and increased toll-like receptor 4 (Tlr4) mRNA expression, suggesting that toxicant exposure induced a heightened inflammatory response at the maternal-fetal interface. Since omega-3 fatty acids exhibit anti-inflammatory activity, in this study, we provided TCDD-exposed males a fish oil-enriched diet prior to mating. Although PTB was common in control females mated to TCDD-exposed males on the standard diet, fish oil supplementation of TCDD-exposed males eliminated PTB in unexposed partners. We also determined the influence of preconception, paternal fish oil supplementation on the placental inflammatory response in late pregnancy (E18.5) by examining the expression of Pgr and Tlr4 mRNA as well as the expression of 15-hydroxyprostaglandin dehydrogenase (PGDH). PGDH catabolizes the inflammatory PGE2 to an inactive form; thus, reduced expression of this enzyme would promote tissue inflammation. Compared with control pregnancies, examination of E18.5 placentas arising from TCDD-exposed males on the standard diet revealed a significant increase in Tlr4 mRNA expression corresponding to a reduction in Pgr mRNA and PGDH protein expression. In contrast, fish oil supplementation of toxicant-exposed males led to normalization of placental expression of both Pgr and Tlr4 mRNA and a marked increase in PGDH expression. These studies suggest that a paternal preconception diet that includes omega-3 fatty acids prevents the toxicant-associated increase in the placental inflammatory response at late gestation, preventing PTB.
- Published
- 2011
- Full Text
- View/download PDF
31. Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations.
- Author
-
Bruner-Tran KL and Osteen KG
- Subjects
- Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Fertility genetics, Male, Maternal Exposure, Mice, Mice, Inbred C57BL, Pregnancy, Premature Birth chemically induced, Prenatal Exposure Delayed Effects genetics, Uterus drug effects, Uterus pathology, Environmental Pollutants toxicity, Epigenesis, Genetic drug effects, Fertility drug effects, Polychlorinated Dibenzodioxins toxicity, Prenatal Exposure Delayed Effects chemically induced
- Abstract
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is a ubiquitous environmental contaminant and known endocrine disruptor. Since humans and animals are most sensitive to toxicant exposure during development, we previously developed a mouse model of in utero TCDD exposure in order to examine the impact of this toxicant on adult reproductive function. Our initial in utero toxicant-exposure study revealed a dose-dependent reduction in uterine sensitivity to progesterone; however, we did not previously explore establishment or maintenance of pregnancy. Thus, in the current study, we examined pregnancy outcomes in adult C57BL/6 mice with a history of developmental TCDD exposure. Herein we demonstrate reduced fertility and an increased incidence of premature birth (PTB) in F1 mice exposed in utero to TCDD as well as in three subsequent generations. Finally, our studies revealed that mice with a history of developmental TCDD exposure exhibit an increased sensitivity to inflammation which further negatively impacted gestation length in all generations examined., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
32. Developmental dioxin exposure of either parent is associated with an increased risk of preterm birth in adult mice.
- Author
-
Ding T, McConaha M, Boyd KL, Osteen KG, and Bruner-Tran KL
- Subjects
- Animals, Female, Gene Expression drug effects, Male, Mice, Mice, Inbred C57BL, Placenta drug effects, Placenta metabolism, Placenta pathology, Placenta Diseases chemically induced, Placenta Diseases metabolism, Placenta Diseases pathology, Pregnancy, RNA, Messenger metabolism, Receptors, Progesterone genetics, Receptors, Progesterone metabolism, Epigenesis, Genetic drug effects, Maternal Exposure adverse effects, Paternal Exposure adverse effects, Polychlorinated Dibenzodioxins toxicity, Premature Birth chemically induced, Prenatal Exposure Delayed Effects chemically induced, Teratogens toxicity
- Abstract
We have previously described diminished uterine progesterone response and increased uterine sensitivity to inflammation in adult female mice with a history of developmental exposure to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin). Since parturition in mammals is an inflammatory process mediated in part by a decline in progesterone action, toxicant-mediated disruption of progesterone receptor (PR) expression at the maternal-fetal interface would likely impact the timing of birth. Therefore, in the current study, we examined pregnancy outcomes in adult female mice with a similar in utero exposure to TCDD. We also examined the impact of in utero TCDD exposure of male mice on pregnancy outcomes in unexposed females since the placenta, a largely paternally derived organ, plays a major role in the timing of normal parturition via inflammatory signaling. Our studies indicate that developmental exposure of either parent to TCDD is associated with preterm birth in a subsequent adult pregnancy due to altered PR expression and placental inflammation., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
33. Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis.
- Author
-
Herington JL, Crispens MA, Carvalho-Macedo AC, Camargos AF, Lebovic DI, Bruner-Tran KL, and Osteen KG
- Subjects
- Animals, Female, Humans, Mice, Mice, Nude, Pioglitazone, Radiation Chimera, Thiazolidinediones therapeutic use, Tissue Adhesions etiology, Tissue Adhesions prevention & control, Tissue Transplantation, Disease Models, Animal, Endometriosis etiology, Endometriosis prevention & control, Endometrium transplantation, Postoperative Complications etiology, Postoperative Complications prevention & control
- Abstract
Objective: To examine the impact of a recent surgery on development of endometriosis-related adhesions in a chimeric model and to determine the therapeutic efficacy of pioglitazone (PIO)., Design: Human endometrial biopsies were maintained in E(2) with or without PIO for 24 h before intraperitoneal injection into immunocompromised mice also treated with or without PIO at multiple time points after peritoneal surgery. The presence and extent of adhesions were examined in animals relative to the initial establishment of experimental endometriosis., Setting: Medical school research center., Patient(s): Endometrial biopsies for experimental studies were provided by normally cycling women without a medical history indicative of endometriosis or adhesions., Intervention(s): None., Main Outcome Measure(s): Examination of the development of endometriosis-related adhesions in an experimental model., Result(s): Without therapeutic intervention, injection of E(2)-treated human endometrial tissue into mice near the time of peritoneal surgery resulted in multiple adhesions and extensive endometriotic-like disease. In contrast, PIO treatment reduced adhesive disease and experimental endometriosis related to surgical injury., Conclusion(s): The presence of human endometrial tissue fragments in the peritoneal cavity of mice with a recent surgical injury promoted development of both adhesive disease and experimental endometriosis. Targeting inflammation and angiogenesis with PIO therapy limited the development of postsurgical adhesions associated with ectopic endometrial growth., (Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
34. Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro.
- Author
-
Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K, and Duleba AJ
- Subjects
- Adolescent, Adult, Animals, Female, Humans, Mice, Mice, Nude, Middle Aged, Resveratrol, Stromal Cells physiology, Young Adult, Endometriosis metabolism, Endometrium cytology, Endometrium drug effects, Stilbenes pharmacology, Stromal Cells drug effects
- Abstract
Endometriosis is a common gynecologic disorder characterized by ectopic attachment and growth of endometrial tissues. Resveratrol is a natural polyphenol with antiproliferative and anti-inflammatory properties. Our objective was to study the effects of resveratrol on human endometriotic implants in a nude mouse model and to examine its impact on human endometrial stromal (HES) cell invasiveness in vitro. Human endometrial tissues were obtained from healthy donors. Endometriosis was established in oophorectomized nude mice by intraperitoneal injection of endometrial tissues. Mice were treated with 17β-estradiol (8 mg, silastic capsule implants) alone (n = 16) or with resveratrol (6 mg/mouse; n = 20) for 10-12 and 18-20 days beginning 1 day after tissue injection. Mice were killed and endometrial implants were evaluated. A Matrigel invasion assay was used to examine the effects of resveratrol on HES cells. We assessed number and size of endometriotic implants in vivo and Matrigel invasion in vitro. Resveratrol decreased the number of endometrial implants per mouse by 60% (P < 0.001) and the total volume of lesions per mouse by 80% (P < 0.001). Resveratrol (10-30 μM) also induced a concentration-dependent reduction of invasiveness of HES by up to 78% (P < 0.0001). Resveratrol inhibits development of endometriosis in the nude mouse and reduces invasiveness of HES cells. These observations may aid in the development of novel treatments of endometriosis.
- Published
- 2011
- Full Text
- View/download PDF
35. Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes.
- Author
-
Bruner-Tran KL, Carvalho-Macedo AC, Duleba AJ, Crispens MA, and Osteen KG
- Subjects
- Adoptive Transfer, Adult, Animals, DNA-Binding Proteins deficiency, Endometriosis pathology, Endometriosis prevention & control, Endometrium pathology, Female, Humans, Interleukin Receptor Common gamma Subunit deficiency, Mice, Models, Animal, Endometriosis immunology, Immunocompromised Host genetics, Leukocyte Transfusion
- Abstract
Objective: To develop a chimeric human/mouse model of experimental endometriosis for the examination of the role of human immune cells in this disease., Design: Laboratory-based study., Setting: University-affiliated medical center., Patient(s): Healthy women undergoing volunteer endometrial biopsies and blood donation., Intervention(s): None., Main Outcome Measure(s): In vivo analysis of the impact of the adoptive transfer of human immune cells into immunocompromised mice receiving autologous human endometrium., Result(s): Similar to our previous data using nude mice, human endometrial tissue fragments injected intraperitoneally into rag2gamma(c) mice readily established experimental disease. However, in this study, we found a statistically significant reduction in the severity of peritoneal disease in rag2gamma(c) mice which also received adoptive transfer of human immune cells compared with mice that did not receive immune cells. Our studies indicate that human immune cells readily track into the ectopic lesions established in mice., Conclusion(s): The ability of immune cells from disease-free women to limit intraperitoneal disease in mice suggests that a robust immune system is protective against the development of endometriosis., (Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
36. Dioxin-like PCBs and endometriosis.
- Author
-
Bruner-Tran KL and Osteen KG
- Subjects
- Adult, Endometrium physiopathology, Environmental Exposure, Female, Fetal Blood chemistry, Humans, Pregnancy, Prenatal Exposure Delayed Effects, United States, Dioxins blood, Endometriosis chemically induced, Environmental Pollutants blood, Polychlorinated Biphenyls blood
- Abstract
A recent survey in the United States identified 287 different chemicals in human cord blood, demonstrating the significant exposure of women and their children to a wide array of environmental toxicants. While reducing contamination and exposure should be an international priority, it is equally appropriate to develop an understanding of the health consequences of increasing world-wide industrialization. Endometriosis, a disease of the female reproductive tract, has emerged as a disease potentially related to environmental exposures. While a number of population-based studies have suggested that a woman's exposure to dioxin-like polychlorinated biphenyls may affect her risk of developing this disease, other studies have failed to find such evidence. In the current manuscript, we will review the limited data regarding polychlorinated biphenyl congeners and endometriosis with a focus on dioxin-like toxicants. We will also discuss the potential importance of early life exposures to these toxicants on the subsequent development of endometriosis.
- Published
- 2010
- Full Text
- View/download PDF
37. The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.
- Author
-
Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, and Lockwood CJ
- Subjects
- Adult, Animals, CHO Cells, Cricetinae, Cricetulus, Drug Delivery Systems, Endometriosis metabolism, Endometriosis pathology, Endothelium, Vascular drug effects, Endothelium, Vascular metabolism, Female, Humans, Immunoconjugates administration & dosage, Immunoglobulin Fc Fragments administration & dosage, Immunoglobulin Fc Fragments pharmacology, Immunotherapy methods, Mice, Mice, Nude, Middle Aged, Neovascularization, Pathologic metabolism, Peritoneal Diseases metabolism, Peritoneal Diseases pathology, Thromboplastin metabolism, Transplantation, Heterologous, Endometriosis therapy, Immunoconjugates pharmacology, Neovascularization, Pathologic therapy, Peritoneal Diseases therapy, Thromboplastin antagonists & inhibitors, Thromboplastin immunology
- Abstract
Endometriosis is a major cause of chronic pain, infertility, medical and surgical interventions, and health care expenditures. Tissue factor (TF), the primary initiator of coagulation and a modulator of angiogenesis, is not normally expressed by the endothelium; however, prior studies have demonstrated that both blood vessels in solid tumors and choroidal tissue in macular degeneration express endothelial TF. The present study describes the anomalous expression of TF by endothelial cells in endometriotic lesions. The immunoconjugate molecule (Icon), which binds with high affinity and specificity to this aberrant endothelial TF, has been shown to induce a cytolytic immune response that eradicates tumor and choroidal blood vessels. Using an athymic mouse model of endometriosis, we now report that Icon largely destroys endometriotic implants by vascular disruption without apparent toxicity, reduced fertility, or subsequent teratogenic effects. Unlike antiangiogenic treatments that can only target developing angiogenesis, Icon eliminates pre-existing pathological vessels. Thus, Icon could serve as a novel, nontoxic, fertility-preserving, and effective treatment for endometriosis.
- Published
- 2010
- Full Text
- View/download PDF
38. Dioxin and endometrial progesterone resistance.
- Author
-
Bruner-Tran KL, Ding T, and Osteen KG
- Subjects
- Animals, Endometriosis metabolism, Endometrium metabolism, Environmental Exposure, Female, Humans, Mice, Receptors, Progesterone drug effects, Receptors, Progesterone metabolism, Endometriosis chemically induced, Endometrium drug effects, Environmental Pollutants toxicity, Polychlorinated Dibenzodioxins toxicity, Progesterone metabolism
- Abstract
Development of endometriosis likely requires multiple, interactive mechanisms involving both the endocrine and immune systems. Environmental toxicants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), are of particular interest as potential contributory agents in the development of this disease because they can disrupt both systems. Nevertheless, defining the potential role that environmental exposure to TCDD plays in the development of endometriosis requires a better understanding of how this toxicant affects the biological processes that promote the disease. Although the disease mechanism(s) responsible for progesterone resistance in the endometrium of endometriosis patients remains speculative, our studies indicate that developmental exposure of mice to TCDD leads to a progesterone-resistant phenotype in adult animals that can persist for several generations. These studies and others underscore the importance of developing a greater understanding of the mechanisms of TCDD action that relate to reproductive disorders such as endometriosis.
- Published
- 2010
- Full Text
- View/download PDF
39. Simvastatin protects against the development of endometriosis in a nude mouse model.
- Author
-
Bruner-Tran KL, Osteen KG, and Duleba AJ
- Subjects
- Adolescent, Adult, Animals, Anticholesteremic Agents pharmacology, Anticholesteremic Agents therapeutic use, Cells, Cultured, Disease Models, Animal, Drug Evaluation, Preclinical, Endometriosis pathology, Estradiol administration & dosage, Female, Humans, Matrix Metalloproteinase 3 metabolism, Mice, Mice, Nude, Middle Aged, Simvastatin administration & dosage, Simvastatin pharmacology, Time Factors, Transplantation, Heterologous, Uterine Diseases pathology, Young Adult, Endometriosis prevention & control, Simvastatin therapeutic use, Uterine Diseases prevention & control
- Abstract
Context: Endometriosis is a common condition associated with infertility and pelvic pain in women. Recent in vitro studies have shown that statins decrease proliferation of endometrial stroma (ES) and inhibit angiogenesis., Objective: The aim was to evaluate effects of simvastatin on development of endometriosis in a nude mouse model., Methods: Proliferative phase human endometrial biopsies were obtained from healthy donors and established as organ cultures or used to isolate ES cells. To establish endometriosis in the nude mouse, endometrial tissues were maintained in 1 nm estradiol (E) for 24 h and subsequently injected into ovariectomized nude mice. Mice (n = 37) were treated with E (8 mg, SILASTIC capsule implants; made in author laboratory) alone or with E plus simvastatin (5 or 25 mg/kg x d) for 10 d beginning 1 d after tissue injection (from three donors). Mice were killed and examined for disease. Effects of simvastatin on matrix metalloproteinase-3 (MMP-3) were evaluated in cultures of ES cells., Primary Outcome: The number and size of endometriotic implants were measured., Results: Simvastatin induced a dose-dependent decrease of the number and size of endometrial implants in mice. At the highest dose of simvastatin, the number of endometrial implants decreased by 87%, and the volume by 98%. Simvastatin also induced a concentration-dependent decrease in MMP-3 in the absence and presence of inflammatory challenge (using IL-1alpha)., Conclusions: Simvastatin exerted a potent inhibitory effect on the development of endometriosis in the nude mouse. Mechanisms of action of simvastatin may include inhibition of MMP-3. The present findings may lead to the development of novel treatments of endometriosis involving statins.
- Published
- 2009
- Full Text
- View/download PDF
40. Dioxin may promote inflammation-related development of endometriosis.
- Author
-
Bruner-Tran KL, Yeaman GR, Crispens MA, Igarashi TM, and Osteen KG
- Subjects
- Animals, Disease Models, Animal, Endometriosis pathology, Endometriosis physiopathology, Endometrium physiology, Environmental Exposure adverse effects, Female, Humans, Models, Biological, Dioxins toxicity, Endometriosis chemically induced, Inflammation chemically induced
- Abstract
Laboratory and population-based studies suggest that exposure to environmental toxicants may be one of several triggers for the development of endometriosis. We discuss evidence that modulation of the endometrial endocrine-immune interface could mechanistically link toxicant exposure to the development of this disease.
- Published
- 2008
- Full Text
- View/download PDF
41. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis.
- Author
-
Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, and Osteen KG
- Subjects
- Animals, Blotting, Western, Cytochrome P-450 CYP1A1 metabolism, Disease Models, Animal, Endometriosis metabolism, Endometrium drug effects, Endometrium metabolism, Endometrium pathology, Estradiol pharmacology, Female, Humans, Immunohistochemistry, Liver drug effects, Liver metabolism, Liver pathology, Male, Mice, Mice, Inbred C57BL, Organ Culture Techniques, Ovariectomy, Pregnancy, Progesterone pharmacology, Receptors, Progesterone metabolism, Sex Factors, Transforming Growth Factor beta2 metabolism, Uterus metabolism, Uterus pathology, Endometriosis pathology, Environmental Pollutants poisoning, Polychlorinated Dibenzodioxins poisoning, Uterus drug effects
- Abstract
Whether environmental toxicants impact an individual woman's risk for developing endometriosis remains uncertain. Although the growth of endometrial glands and stroma at extra-uterine sites is associated with retrograde menstruation, our studies suggest that reduced responsiveness to progesterone may increase the invasive capacity of endometrial tissue in women with endometriosis. Interestingly, our recent studies using isolated human endometrial cells in short-term culture suggest that experimental exposure to the environmental contaminant 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD) can alter the expression of progesterone receptor isotypes. Compared to adult exposure, toxicant exposure during development can exert a significantly greater biological impact, potentially affecting the incidence of endometriosis in adults. To address this possibility, we exposed mice to TCDD at critical developmental time points and subsequently examined uterine progesterone receptor expression and steroid responsive transforming growth factor-beta2 expression in adult animals. We find that the uterine phenotype of toxicant-exposed mice is markedly similarly to the endometrial phenotype of women with endometriosis.
- Published
- 2007
- Full Text
- View/download PDF
42. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
- Author
-
Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, and Osteen KG
- Subjects
- Adolescent, Adult, Blotting, Western, Cells, Cultured, Down-Regulation drug effects, Endometriosis pathology, Endometrium drug effects, Endometrium pathology, Female, Humans, Matrix Metalloproteinase 3 genetics, Matrix Metalloproteinase 7 genetics, Middle Aged, Organ Culture Techniques, Stromal Cells metabolism, Benzoxazines pharmacology, Benzoxazines therapeutic use, Endometriosis drug therapy, Endometrium metabolism, Matrix Metalloproteinase 3 biosynthesis, Matrix Metalloproteinase 7 biosynthesis, Receptors, Progesterone agonists, Thiones pharmacology, Thiones therapeutic use
- Abstract
Context: Endometriosis, the growth of endometrial tissue outside the uterus, is principally an estrogen-dependent disease. In contrast, exposure to progesterone during pregnancy or therapeutically has been shown to provide benefit to some women with this disease. However, recent research suggests that the presence of endometriosis impairs the capacity of the eutopic endometrium to respond to endogenous progesterone., Objective: Reduced progesterone responsiveness results in an elevated endometrial expression of matrix metalloproteinases (MMPs) during the secretory phase of the menstrual cycle in women with endometriosis. Although cyclic MMP expression is critical for endometrial growth and remodeling, the failure of progesterone to down-regulate MMPs may impair nidation and promote the invasive establishment of endometriosis. In the current study we examined the ability of a newly developed progesterone receptor (PR) agonist, tanaproget (TNPR), to down-regulate endometrial MMP expression in vitro and regress experimental endometriosis in vivo., Setting: This study was performed at a university-based medical center., Participants: Asymptomatic volunteers and patients with endometriosis were studied., Main Outcome Measures: We examined the ability of TNPR to down-regulate endometrial MMP expression in vitro compared with that of natural progesterone and two currently marketed synthetic steroidal progestins. Using a human/mouse model of endometriosis, we also tested the in vivo ability of TNPR to regress ectopic lesions established by tissues with reduced progesterone sensitivity., Results: TNPR effectively down-regulated MMP expression in vitro and induced significant reduction of lesions in mice with disease established by tissues from endometriosis patients., Conclusion: Given the positive preclinical pharmacological profile of TNPR that has recently been reported, additional development of this compound for the treatment of endometriosis is warranted.
- Published
- 2006
- Full Text
- View/download PDF
43. Endometrial biology and the etiology of endometriosis.
- Author
-
Osteen KG, Bruner-Tran KL, and Eisenberg E
- Subjects
- Endometriosis pathology, Endometrium pathology, Female, Humans, Endometriosis etiology, Endometrium physiology
- Abstract
Two recent studies reported in this issue of Fertility and Sterility have explored important issues regarding the understanding and diagnosing of endometriosis. These studies emphasize the complexity of endometriosis and underscore the different roles of clinicians and translational scientists in exploring this disease.
- Published
- 2005
- Full Text
- View/download PDF
44. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
- Author
-
Igarashi TM, Bruner-Tran KL, Yeaman GR, Lessey BA, Edwards DP, Eisenberg E, and Osteen KG
- Subjects
- Adult, Cells, Cultured, Coculture Techniques, Endometriosis genetics, Endometrium cytology, Female, Gene Expression Regulation drug effects, Gene Expression Regulation physiology, Humans, Matrix Metalloproteinases biosynthesis, Matrix Metalloproteinases genetics, Receptors, Progesterone genetics, Statistics, Nonparametric, Stromal Cells cytology, Stromal Cells drug effects, Stromal Cells metabolism, Endometriosis metabolism, Endometrium drug effects, Endometrium metabolism, Polychlorinated Dibenzodioxins toxicity, Receptors, Progesterone biosynthesis
- Abstract
Objective: To analyze endometrial progesterone receptor (PR) expression in women with endometriosis compared with disease-free women and to assess the impact of in vitro 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure on PR isotype expression., Design: Controlled laboratory study., Setting: University medical center., Patient(s): Healthy volunteers and women with surgically diagnosed endometriosis., Intervention(s): None., Main Outcome Measure(s): Analysis of in vivo PR-A and PR-B expression in endometrium from women with and without endometriosis. The impact of in vitro TCDD exposure on PR-B/PR-A ratio and cell-specific matrix metalloproteinase (MMP) expression was also determined., Result(s): The PR-B/PR-A ratio was lower in endometrial tissues from women with endometriosis compared with normal tissues. A similar ratio was induced in normal stromal cells cocultured with epithelial cells and exposed to TCDD. Disruption of stromal PR expression following TCDD exposure was associated with a failure of P-mediated down-regulation of both stromal-specific pro-MMP-3 and epithelial-specific pro-MMP-7., Conclusion(s): Our data suggest that reduced progesterone (P) sensitivity in the endometrium of women with endometriosis may be related to an altered pattern of PR expression. The ability of TCDD to selectively down-regulate stromal PR-B expression and increase MMP expression in both stromal and epithelial cells suggests that exposure to this toxin may negatively impact P-mediated cell-cell communication in the human endometrium.
- Published
- 2005
- Full Text
- View/download PDF
45. The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.
- Author
-
Kurita T, Medina R, Schabel AB, Young P, Gama P, Parekh TV, Brody J, Cunha GR, Osteen KG, Bruner-Tran KL, and Gold LI
- Subjects
- Animals, Cell Proliferation, Cells, Cultured, Epithelial Cells drug effects, Estrogen Receptor alpha genetics, Female, Humans, Mice, Mice, Inbred Strains, Protein Structure, Tertiary genetics, Stromal Cells drug effects, Estradiol pharmacology, Estrogen Receptor alpha metabolism, Receptors, Progesterone metabolism, Uterus cytology, Uterus drug effects
- Abstract
The activation function-1 (AF-1) domain of the estrogen receptor alpha (ERalpha) in stromal cells has been shown to be required for epithelial responses to estrogen in the mouse uterus. To investigate the role of the stroma in estrogenic responses of human uterine epithelium (hUtE), human/mouse chimeric uteri composed of human epithelium and mouse stroma were prepared as tissue recombinants (TR) that were grown in vivo under the renal capsule of female nude mouse hosts. In association with mouse uterine stroma (mUtS), hUtE formed normal glands surrounded by mouse endometrial stroma and the human epithelium influenced the differentiation of stroma into myometrium, such that a histologically normal appearing uterine tissue was formed. The hUtE showed a similar proliferative response and increase in progesterone receptors (PR) in response to 17beta-estradiol (E2) in association with either human or mUtS, as TRs. However, under identical endocrine and micro-environmental conditions, hUtE required 5-7 days exposure to E2 rather than 1 day, as shown for mouse uterine epithelium, to obtain a maximal proliferative response. Moreover, this extended length of E2 exposure inhibited mouse epithelial proliferation in the presence of mouse stroma. In addition, unlike the mouse epithelium, which does not proliferate or show regulation of PR expression in response to E2 in association with uterine stroma derived from mice that are null for the AF-1 domain of ERalpha, hUtE proliferates and PR are up-regulated in response to E2 in association genetically identical ERalpha knock-out mouse stromal cells. These results clearly demonstrate fundamental differences between mouse and human uterine epithelia with respect to the mechanisms that regulate estrogen-induced proliferation and expression of PR. Moreover, we show that genetically engineered mouse models could potentially aid in dissecting molecular pathways of stromal epithelial interactions in the human uterus.
- Published
- 2005
- Full Text
- View/download PDF
46. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.
- Author
-
Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, and Lyttle CR
- Subjects
- Adolescent, Adult, Animals, Biopsy, Disease Models, Animal, Endometriosis pathology, Endometrium pathology, Estrogen Receptor beta genetics, Female, Humans, Mice, Mice, Nude, Middle Aged, Organ Culture Techniques, Ovariectomy, Oxazoles chemistry, RNA, Messenger analysis, Endometriosis drug therapy, Endometrium drug effects, Estrogen Receptor beta agonists, Oxazoles pharmacology
- Abstract
Background: Endometriosis is a common gynaecological problem of uncertain aetiology. It affects primarily young, reproductive-aged women and can result in chronic pelvic pain and infertility. Current approved therapies have significant side-effects and hysterectomy is employed as a final solution. ERB-041 is a selective estrogen receptor-beta (ERbeta) agonist that has anti-inflammatory activity in preclinical models of arthritis and inflammatory bowel disease, but is inactive in many preclinical models of classic estrogen activity. Because endometriosis is now thought to be, at least in part, an inflammatory disease, we evaluated ERB-041's activity in an experimentally induced model of endometriosis., Methods: Athymic nude mice (ovariectomized or intact) were implanted with tissue fragments of normal human endometrium. After establishment of lesions for 11-14 days, mice were treated with ERB-041 for 15-17 days. Upon euthanasia, the number of lesions, their size and location were noted. Five lesions were recovered for RNA analysis., Results: Across six studies, ERB-041 caused complete lesion regression in 40-75% of the mice studied. The compound appeared to be equally effective in gonad-intact as in ovariectomized mice, and analysed recovered lesions expressed ERalpha but not ERbeta mRNA., Conclusions: ERB-041 and possibly other ERbeta selective agonists may be a useful new approach to treating endometriosis.
- Published
- 2005
- Full Text
- View/download PDF
47. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
- Author
-
Osteen KG, Bruner-Tran KL, and Eisenberg E
- Subjects
- Female, Humans, Pregnancy, Risk Factors, Endometriosis epidemiology, Endometriosis physiopathology, Endometrium physiology, Progesterone physiology
- Abstract
Objective: To discuss the role that reduced endometrial responsiveness to progesterone (P) might play in the pathophysiology of endometriosis., Design: A review of experimental evidence regarding the failure of P to regulate the expression of matrix metalloproteinases (MMPs) in the endometrium of patients with endometriosis., Conclusion(s): Progesterone and locally produced differentiation factors act cooperatively to reduce MMP expression by maternal endometrial cells within the pro-inflammatory micro-environment of early pregnancy. Our in vitro studies with normal human endometrium demonstrate that prior P exposure not only down-regulates MMP expression, but also limits the ability of locally produced proinflammatory cytokines to stimulate expression of these enzymes. In contrast, endometrial tissues from women with endometriosis demonstrate an altered response to P, allowing a continuous expression of MMPs throughout the secretory phase. Although the factors that influence the loss of P sensitivity in the endometrium of patients with endometriosis have not yet been defined, alterations in cell-cell communication seem to contribute to dysregulated MMP expression. Specifically, proinflammatory cytokines produced by epithelial cells oppose stromal cell responses to P, inhibiting production of key differentiation factors necessary for cell-specific MMP regulation. The resulting loss in normal MMP regulation enhances the invasive capacity of endometrial tissue, promoting ectopic establishment in an experimental model.
- Published
- 2005
- Full Text
- View/download PDF
48. Steroid and cytokine regulation of matrix metalloproteinases and the pathophysiology of endometriosis.
- Author
-
Osteen KG, Igarashi TM, Yeaman GR, and Bruner-Tran KL
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Infertility, Female etiology, Primates, Cytokines physiology, Endometriosis physiopathology, Matrix Metalloproteinases metabolism, Steroids physiology
- Published
- 2004
49. Antiangiogenic agents are effective inhibitors of endometriosis.
- Author
-
Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, and Smith SK
- Subjects
- Animals, Antibodies pharmacology, Blood Vessels pathology, Endometrium blood supply, Endothelial Growth Factors antagonists & inhibitors, Endothelial Growth Factors immunology, Female, Humans, Intercellular Signaling Peptides and Proteins immunology, Lymphokines immunology, Mice, Mice, Nude, Rats, Rats, Wistar, Solubility, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-1 physiology, Vascular Endothelial Growth Factors, Angiogenesis Inhibitors pharmacology, Endometriosis prevention & control
- Abstract
Endometriosis is a disease in which the lining of the uterus (endometrium), shed at the time of menstruation, becomes established at sites such as the peritoneum and ovaries. These explants develop a rich blood supply that enables them to survive and grow. We hypothesized that inhibitors of angiogenesis would prevent this growth by disrupting sensitive vessels supplying endometriotic lesions. Vessels sensitive to angiogenic antagonism have few associations with pericyte cells. The vessels supplying human endometriotic lesions were immunohistochemically characterized and found to be predominantly pericyte free. A model in which human endometrium is implanted into nude mice was used to test the effects of two antagonists of the angiogenic growth factor, vascular endothelial cell growth factor A. Soluble truncated receptor (flt-1; P = 0.002) and an affinity-purified antibody to human vascular endothelial cell growth factor A (P = 0.03) significantly inhibited the growth of nude mouse explants. Pericyte-free vessels were shown to supply endometrial lesions in nude mice and were disrupted in lesions taken from soluble flt-1-treated mice. In summary, antiangiogenic agents inhibited the growth of explants in an in vivo model of endometriosis by disrupting the vascular supply, and this effect is likely to apply to the human disease. These findings suggest that antiangiogenic agents may provide a novel therapeutic approach for the treatment of endometriosis.
- Published
- 2003
- Full Text
- View/download PDF
50. Matrix metalloproteinases and endometriosis.
- Author
-
Osteen KG, Yeaman GR, and Bruner-Tran KL
- Subjects
- Animals, Endometriosis physiopathology, Female, Gene Expression Regulation, Humans, Matrix Metalloproteinases genetics, Menstruation, Multigene Family genetics, Tissue Inhibitor of Metalloproteinases metabolism, Endometriosis etiology, Matrix Metalloproteinases metabolism
- Abstract
Retrograde menstruation represents a plausible explanation for the development of most cases of endometriosis; nevertheless, additional factors must contribute to the development of disease in only 10 to 20% of women. The discriminating factor(s) in determining the development of active endometriosis probably involves a complex array of potentially interactive influences including steroid exposure, immunological disturbances, genetic predisposition, and, perhaps, environmental toxin exposure. Matrix metalloproteinases (MMPs), enzymes that mediate normal tissue turnover including endometrial breakdown at menstruation, appear to be involved in the invasive establishment of the disease. In addition, several MMPs appear to be inappropriately expressed in the endometrium of women with this disease in association with a reduced sensitivity to progesterone. Altered regulation of endometrial MMP expression in response to steroids may represent a mechanism linking the invasive potential of refluxed endometrium to the establishment of this disease only in certain women.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.